(NASDAQ:ALT) NEW YORK, Sept. 2, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Altimmune, Inc. ("Altimmune" or the "Company") (NASDAQ: ALT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Altimmune investors who were adversely...
Related Questions
What potential effect will the class action lawsuit have on Altimmune's short‑term stock volatility?
When is the deadline to file claims and how might the filing period influence market perception?
Does the lawsuit expose any material liabilities that could affect Altimmune's upcoming financial disclosures or R&D funding?